North Shore Hematology Oncology Associates — East Setauket, New York

Public research footprint of North Shore Hematology Oncology Associates, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Small Cell Lung Cancer · Diffuse Large B-Cell Lymphoma Refractory · Metastatic Colorectal Cancer

Recently updated registry entries

NCT02546986 — Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic… (Terminated)
NCT03523585 — DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has… (Completed)
NCT03480646 — ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at North Shore Hematology Oncology Associates?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.